These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 8977323
1. Intracellular co-localization of Trypanosoma cruzi and inducible nitric oxide synthase (iNOS): evidence for dual pathway of iNOS induction. Rottenberg ME, Castaños-Velez E, de Mesquita R, Laguardia OG, Biberfeld P, Orn A. Eur J Immunol; 1996 Dec; 26(12):3203-13. PubMed ID: 8977323 [Abstract] [Full Text] [Related]
3. Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo: the roles of macrophages, endogenous IFN-gamma, and TNF receptor-1-mediated signaling. Salkowski CA, Detore G, McNally R, van Rooijen N, Vogel SN. J Immunol; 1997 Jan 15; 158(2):905-12. PubMed ID: 8993010 [Abstract] [Full Text] [Related]
4. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Muñoz-Fernández MA, Fernández MA, Fresno M. Eur J Immunol; 1992 Feb 15; 22(2):301-7. PubMed ID: 1537373 [Abstract] [Full Text] [Related]
5. Trypanosoma cruzi: Tc52 released protein-induced increased expression of nitric oxide synthase and nitric oxide production by macrophages. Fernandez-Gomez R, Esteban S, Gomez-Corvera R, Zoulika K, Ouaissi A. J Immunol; 1998 Apr 01; 160(7):3471-9. PubMed ID: 9531308 [Abstract] [Full Text] [Related]
6. Timing of expression of inflammatory mediators in skeletal muscles from mice acutely infected with the RA strain of Trypanosoma cruzi. Cutrullis RA, Postan M, Petray PB, Corral RS. Pathobiology; 2009 Apr 01; 76(4):170-80. PubMed ID: 19571606 [Abstract] [Full Text] [Related]
7. Neurodegeneration and increased production of nitrotyrosine, nitric oxide synthase, IFN-gamma and S100beta protein in the spinal cord of IL-12p40-deficient mice infected with Trypanosoma cruzi. Bombeiro AL, D'Império Lima MR, Chadi G, Alvarez JM. Neuroimmunomodulation; 2010 Apr 01; 17(2):67-78. PubMed ID: 19923851 [Abstract] [Full Text] [Related]
8. Bryostatin-1 and IFN-gamma synergize for the expression of the inducible nitric oxide synthase gene and for nitric oxide production in murine macrophages. Taylor LS, Cox GW, Melillo G, Bosco MC, Espinoza-Delgado I. Cancer Res; 1997 Jun 15; 57(12):2468-73. PubMed ID: 9192827 [Abstract] [Full Text] [Related]
9. IFN-gamma, but not nitric oxide or specific IgG, is essential for the in vivo control of low-virulence Sylvio X10/4 Trypanosoma cruzi parasites. Marinho CR, Nuñez-Apaza LN, Martins-Santos R, Bastos KR, Bombeiro AL, Bucci DZ, Sardinha LR, Lima MR, Alvarez JM. Scand J Immunol; 2007 Jun 15; 66(2-3):297-308. PubMed ID: 17635807 [Abstract] [Full Text] [Related]
10. Interferon-gamma induced nitric oxide mediates in vitro neuronal damage by Trypanosoma cruzi-infected macrophages. Almeida-Leite CM, Galvão LM, Afonso LC, Cunha FQ, Arantes RM. Neurobiol Dis; 2007 Jan 15; 25(1):170-8. PubMed ID: 17056264 [Abstract] [Full Text] [Related]
11. Leishmania sp: comparative study with Toxoplasma gondii and Trypanosoma cruzi in their ability to initialize IL-12 and IFN-gamma synthesis. Oliveira MA, Santiago HC, Lisboa CR, Ceravollo IP, Trinchieri G, Gazzinelli RT, Vieira LQ. Exp Parasitol; 2000 Jun 15; 95(2):96-105. PubMed ID: 10910710 [Abstract] [Full Text] [Related]
12. Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection. Abrahamsohn IA, Coffman RL. Exp Parasitol; 1996 Nov 15; 84(2):231-44. PubMed ID: 8932773 [Abstract] [Full Text] [Related]
13. Trypanosoma cruzi: the effect of nitric oxide synthesis inhibition on the CD4 T cell response to the trans-sialidase superfamily. Millar AE, Kahn SJ. Exp Parasitol; 2000 Feb 15; 94(2):84-91. PubMed ID: 10673344 [Abstract] [Full Text] [Related]
14. Synergistic protection by specific antibodies and interferon against infection by Trypanosoma cruzi in vitro. Plata F, Wietzerbin J, Pons FG, Falcoff E, Eisen H. Eur J Immunol; 1984 Oct 15; 14(10):930-5. PubMed ID: 6208038 [Abstract] [Full Text] [Related]
15. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections. Reed SG. J Immunol; 1988 Jun 15; 140(12):4342-7. PubMed ID: 3131431 [Abstract] [Full Text] [Related]
16. Type 1 immunity provides both optimal mucosal and systemic protection against a mucosally invasive, intracellular pathogen. Hoft DF, Eickhoff CS. Infect Immun; 2005 Aug 15; 73(8):4934-40. PubMed ID: 16041007 [Abstract] [Full Text] [Related]
18. Glycoconjugates isolated from Trypanosoma cruzi but not from Leishmania species membranes trigger nitric oxide synthesis as well as microbicidal activity in IFN-gamma-primed macrophages. Camargo MM, Andrade AC, Almeida IC, Travassos LR, Gazzinelli RT. J Immunol; 1997 Dec 15; 159(12):6131-9. PubMed ID: 9550414 [Abstract] [Full Text] [Related]